vs

Side-by-side financial comparison of Air Products (APD) and Invesco (IVZ). Click either name above to swap in a different company.

Air Products is the larger business by last-quarter revenue ($3.2B vs $1.7B, roughly 1.9× Invesco). Air Products runs the higher net margin — 22.9% vs -58.9%, a 81.7% gap on every dollar of revenue. On growth, Air Products posted the faster year-over-year revenue change (8.8% vs 6.2%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 3.1%).

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasificati...

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

APD vs IVZ — Head-to-Head

Bigger by revenue
APD
APD
1.9× larger
APD
$3.2B
$1.7B
IVZ
Growing faster (revenue YoY)
APD
APD
+2.6% gap
APD
8.8%
6.2%
IVZ
Higher net margin
APD
APD
81.7% more per $
APD
22.9%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
3.1%
APD

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
APD
APD
IVZ
IVZ
Revenue
$3.2B
$1.7B
Net Profit
$724.8M
$-995.9M
Gross Margin
31.1%
Operating Margin
-86.2%
Net Margin
22.9%
-58.9%
Revenue YoY
8.8%
6.2%
Net Profit YoY
166.6%
-575.8%
EPS (diluted)
$3.19
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APD
APD
IVZ
IVZ
Q1 26
$3.2B
Q4 25
$3.1B
$1.7B
Q3 25
$3.2B
$1.6B
Q2 25
$3.0B
$1.5B
Q1 25
$2.9B
$1.5B
Q4 24
$2.9B
$1.6B
Q3 24
$3.2B
$1.5B
Q2 24
$3.0B
$1.5B
Net Profit
APD
APD
IVZ
IVZ
Q1 26
$724.8M
Q4 25
$678.2M
$-995.9M
Q3 25
$4.9M
$356.4M
Q2 25
$713.8M
$197.4M
Q1 25
$-1.7B
$171.1M
Q4 24
$617.4M
$209.3M
Q3 24
$1.9B
$55.0M
Q2 24
$696.6M
$132.2M
Gross Margin
APD
APD
IVZ
IVZ
Q1 26
31.1%
Q4 25
32.1%
Q3 25
32.3%
Q2 25
32.5%
Q1 25
29.6%
Q4 24
31.2%
Q3 24
34.0%
Q2 24
32.8%
Operating Margin
APD
APD
IVZ
IVZ
Q1 26
Q4 25
23.7%
-86.2%
Q3 25
0.5%
16.5%
Q2 25
26.2%
14.1%
Q1 25
-79.8%
18.1%
Q4 24
22.0%
19.6%
Q3 24
76.1%
6.6%
Q2 24
24.7%
13.9%
Net Margin
APD
APD
IVZ
IVZ
Q1 26
22.9%
Q4 25
21.9%
-58.9%
Q3 25
0.2%
21.7%
Q2 25
23.6%
13.0%
Q1 25
-59.3%
11.2%
Q4 24
21.1%
13.1%
Q3 24
61.2%
3.6%
Q2 24
23.3%
8.9%
EPS (diluted)
APD
APD
IVZ
IVZ
Q1 26
$3.19
Q4 25
$3.04
$-2.61
Q3 25
$0.03
$0.66
Q2 25
$3.20
$-0.03
Q1 25
$-7.77
$0.38
Q4 24
$2.77
$0.46
Q3 24
$8.75
$0.12
Q2 24
$3.13
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APD
APD
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$17.4M
$1.8B
Stockholders' EquityBook value
$18.1M
$12.2B
Total Assets
$41.6M
$27.1B
Debt / EquityLower = less leverage
0.96×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APD
APD
IVZ
IVZ
Q1 26
Q4 25
$1.0B
$1.0B
Q3 25
$1.9B
$973.1M
Q2 25
$2.3B
$922.7M
Q1 25
$1.6B
$821.7M
Q4 24
$2.0B
$986.5M
Q3 24
$3.0B
$1.0B
Q2 24
$2.4B
$878.5M
Total Debt
APD
APD
IVZ
IVZ
Q1 26
$17.4M
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Stockholders' Equity
APD
APD
IVZ
IVZ
Q1 26
$18.1M
Q4 25
$15.4B
$12.2B
Q3 25
$15.0B
$14.0B
Q2 25
$15.5B
$13.9B
Q1 25
$14.7B
$14.7B
Q4 24
$16.7B
$14.6B
Q3 24
$17.0B
$14.8B
Q2 24
$15.1B
$14.6B
Total Assets
APD
APD
IVZ
IVZ
Q1 26
$41.6M
Q4 25
$41.2B
$27.1B
Q3 25
$41.1B
$28.4B
Q2 25
$41.7B
$28.5B
Q1 25
$38.9B
$28.1B
Q4 24
$40.0B
$27.0B
Q3 24
$39.6B
$27.5B
Q2 24
$37.0B
$27.2B
Debt / Equity
APD
APD
IVZ
IVZ
Q1 26
0.96×
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APD
APD
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
56.4%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APD
APD
IVZ
IVZ
Q1 26
Q4 25
$900.7M
$455.8M
Q3 25
$606.2M
Q2 25
$855.8M
$547.9M
Q1 25
$328.1M
$-84.6M
Q4 24
$811.7M
$316.9M
Q3 24
$438.4M
Q2 24
$1.3B
$489.1M
Free Cash Flow
APD
APD
IVZ
IVZ
Q1 26
Q4 25
$-350.5M
$432.2M
Q3 25
$586.4M
Q2 25
$-640.0M
$530.4M
Q1 25
$-1.6B
$-108.0M
Q4 24
$-1.3B
$309.9M
Q3 24
$410.0M
Q2 24
$-345.2M
$462.4M
FCF Margin
APD
APD
IVZ
IVZ
Q1 26
Q4 25
-11.3%
25.5%
Q3 25
35.7%
Q2 25
-21.2%
35.0%
Q1 25
-53.6%
-7.1%
Q4 24
-44.5%
19.5%
Q3 24
27.1%
Q2 24
-11.6%
31.2%
Capex Intensity
APD
APD
IVZ
IVZ
Q1 26
56.4%
Q4 25
40.3%
1.4%
Q3 25
47.9%
1.2%
Q2 25
49.5%
1.2%
Q1 25
64.9%
1.5%
Q4 24
72.2%
0.4%
Q3 24
65.1%
1.9%
Q2 24
53.8%
1.8%
Cash Conversion
APD
APD
IVZ
IVZ
Q1 26
Q4 25
1.33×
Q3 25
1.70×
Q2 25
1.20×
2.78×
Q1 25
-0.49×
Q4 24
1.31×
1.51×
Q3 24
7.97×
Q2 24
1.81×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APD
APD

Segment breakdown not available.

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons